Alera Research

GLP-1 receptor agonist studied for glycemic control and significant weight reduction.

Dual GIP/GLP-1 receptor agonist studied for weight loss and type 2 diabetes management.

Dual GIP/GLP-1 receptor agonist studied for weight loss and type 2 diabetes management.

Triple GIP/GLP-1/glucagon receptor co-agonist in clinical trials for obesity and metabolic disease.

Triple GIP/GLP-1/glucagon receptor co-agonist in clinical trials for obesity and metabolic disease.

Synthetic pentadecapeptide derived from gastric juice studied for tendon, ligament, and gut healing.

Synthetic fragment of Thymosin Beta-4 researched for wound healing, muscle repair, and anti-inflammation.

Copper-bound tripeptide studied for skin rejuvenation, hair growth, and wound healing.

Selective GH secretagogue and ghrelin mimetic studied for growth hormone release with minimal side effects.

Mitochondria-encoded peptide studied for metabolic regulation, insulin sensitivity, and exercise mimicry.

Essential coenzyme studied for cellular energy metabolism, sirtuin activation, and longevity pathways.

Melanocortin receptor agonist (FDA-approved as Vyleesi) studied for sexual dysfunction in men and women.

Truncated analogue of endogenous GHRH studied for stimulating pulsatile GH secretion.

FDA-approved GHRH analogue researched for visceral fat reduction and GH deficiency.

Long-acting GHRH analogue that stimulates growth hormone secretion; often combined with Ipamorelin.

Selective GH secretagogue and ghrelin mimetic studied for growth hormone release with minimal side effects.

Synthetic pentadecapeptide derived from gastric juice studied for tendon, ligament, and gut healing.

Mitochondria-targeted tetrapeptide studied for cardioprotection and mitochondrial bioenergetics.

Neuropeptide studied for promoting slow-wave sleep, stress modulation, and anti-oxidative effects.

Tripeptide derived from alpha-MSH studied for gut inflammation and wound healing.

Non-selective melanocortin receptor agonist studied for tanning, libido, and appetite suppression.

Long-acting variant of IGF-1 studied for anabolic signaling, muscle hypertrophy, and satellite cell activation.

C-terminal fragment of hGH studied for lipolysis and fat-burning without IGF-1 elevation.